Intravenous Cyclophosphamide Pulse Therapy in the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease: A Long Term Study

OBJECTIVE: Interstitial lung disease (ILD) frequently complicates systemic sclerosis (SSc). Cyclophosphamide (CYC) is a promising immunosuppressive therapy for SSc-related ILD. Our objective was to investigate the effectiveness of an intravenous CYC (iv CYC) pulse regime in SSc-related ILD during tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Simeón-Aznar, C.P, Fonollosa-Plá, V, Tolosa-Vilella, C, Selva-O´Callaghan, A, Solans-Laqué, R, Palliza, E, Muñoz, X, Vilardell-Tarrés, M
Formato: Texto
Lenguaje:English
Publicado: Bentham Open 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606648/
https://www.ncbi.nlm.nih.gov/pubmed/19340324
http://dx.doi.org/10.2174/1874306400802010039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606648/
https://www.ncbi.nlm.nih.gov/pubmed/19340324
http://dx.doi.org/10.2174/1874306400802010039

Ejemplares similares